HB3087 EngrossedLRB104 09442 RLC 19502 b

1    AN ACT concerning criminal law.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Methamphetamine Precursor Control Act is
5amended by changing Section 25 as follows:
 
6    (720 ILCS 648/25)
7    Sec. 25. Pharmacies.
8    (a) No targeted methamphetamine precursor may be knowingly
9distributed through a pharmacy, including a pharmacy located
10within, owned by, operated by, or associated with a retail
11distributor unless all terms of this Section are satisfied.
12    (b) Any targeted methamphetamine precursor other than a
13convenience package or a liquid, including but not limited to
14any targeted methamphetamine precursor in liquid-filled
15capsules, shall: be packaged in blister packs, with each
16blister containing not more than 2 dosage units, or when the
17use of blister packs is technically infeasible, in unit dose
18packets. Each targeted package shall contain no more than
193,600 3,000 milligrams of ephedrine or pseudoephedrine, their
20salts or optical isomers, or salts of optical isomers.
21    (c) The targeted methamphetamine precursor shall be stored
22behind the pharmacy counter and distributed by a pharmacist or
23pharmacy technician licensed under the Pharmacy Practice Act,

 

 

HB3087 Engrossed- 2 -LRB104 09442 RLC 19502 b

1or by an agent of the pharmacist or pharmacy technician.
2    (d) Any retail distributor operating a pharmacy, and any
3pharmacist or pharmacy technician involved in the transaction
4or transactions, shall ensure that any person purchasing,
5receiving, or otherwise acquiring the targeted methamphetamine
6precursor complies with subsection (a) of Section 20 of this
7Act.
8    (e) Any retail distributor operating a pharmacy, and any
9pharmacist or pharmacy technician involved in the transaction
10or transactions, shall verify that:
11        (1) The person purchasing, receiving, or otherwise
12    acquiring the targeted methamphetamine precursor is 18
13    years of age or older and resembles the photograph of the
14    person on the government-issued identification presented
15    by the person; and
16        (2) The name entered into the log referred to in
17    subsection (a) of Section 20 of this Act corresponds to
18    the name on the government-issued identification presented
19    by the person.
20    (f) The logs referred to in subsection (a) of Section 20 of
21this Act shall be kept confidential, maintained for not less
22than 4 years, and made available for inspection and copying by
23any law enforcement officer upon request of that officer.
24These logs shall be kept in an electronic format as required by
25the Methamphetamine Precursor Tracking Act.
26    (g) No retail distributor operating a pharmacy, and no

 

 

HB3087 Engrossed- 3 -LRB104 09442 RLC 19502 b

1pharmacist or pharmacy technician, shall knowingly distribute
2any targeted methamphetamine precursor to any person under 18
3years of age.
4    (h) No retail distributor operating a pharmacy, and no
5pharmacist or pharmacy technician, shall knowingly distribute
6to a single person more than 3.6 grams per day or 7.5 grams in
7a 30-day period of a targeted methamphetamine precursor 2
8targeted packages in a single retail transaction.
9    (i) No retail distributor operating a pharmacy, and no
10pharmacist or pharmacy technician, shall knowingly distribute
11to a single person in any 30-day period products containing
12more than a total of 7,500 milligrams of ephedrine or
13pseudoephedrine, their salts or optical isomers, or salts of
14optical isomers.
15    (j) A pharmacist or pharmacy technician may distribute a
16targeted methamphetamine precursor to a person who is without
17a form of identification specified in paragraph (1) of
18subsection (a) of Section 20 of this Act only if all other
19provisions of this Act are followed and either:
20        (1) the person presents a driver's license issued
21    without a photograph by the State of Illinois pursuant to
22    the Illinois Administrative Code, Title 92, Section
23    1030.90(b)(1) or 1030.90(b)(2); or
24        (2) the person is known to the pharmacist or pharmacy
25    technician, the person presents some form of
26    identification, and the pharmacist or pharmacy technician

 

 

HB3087 Engrossed- 4 -LRB104 09442 RLC 19502 b

1    reasonably believes that the targeted methamphetamine
2    precursor will be used for a legitimate medical purpose
3    and not to manufacture methamphetamine.
4    (k) When a pharmacist or pharmacy technician distributes a
5targeted methamphetamine precursor to a person according to
6the procedures set forth in this Act, and the pharmacist or
7pharmacy technician does not have access to a working cash
8register at the pharmacy counter, the pharmacist or pharmacy
9technician may instruct the person to pay for the targeted
10methamphetamine precursor at a cash register located elsewhere
11in the retail establishment, whether that register is operated
12by a pharmacist, pharmacy technician, or other employee or
13agent of the retail establishment.
14(Source: P.A. 96-50, eff. 10-21-09; 97-670, eff. 1-19-12.)
 
15    Section 10. The Methamphetamine Precursor Tracking Act is
16amended by changing Sections 15 and 30 as follows:
 
17    (720 ILCS 649/15)
18    Sec. 15. General provisions.
19    (a) Structure. There is established a statewide precursor
20tracking program coordinated and administered by the Illinois
21State Police to track purchases of targeted methamphetamine
22precursors across multiple locations for the purposes stated
23in Section 5 of this Act. Every covered pharmacy must comply
24with this Act. The tracking program created by this Act shall

 

 

HB3087 Engrossed- 5 -LRB104 09442 RLC 19502 b

1be the sole methamphetamine precursor tracking program in
2Illinois.
3    (b) Transmission of electronic transaction records. Unless
4otherwise provided in this Act, each time a covered pharmacy
5distributes a targeted methamphetamine precursor to a
6recipient, the pharmacy shall transmit an electronic
7transaction record to the Central Repository.
8    (c) Notification. The Illinois Department of Financial and
9Professional Regulation shall notify pharmacies seeking
10licensure in Illinois of their obligation to comply with the
11requirements of this Act.
12    (d) Electronic transmission. Starting on the effective
13date of this Act and continuing thereafter, covered pharmacies
14shall transmit all electronic transaction records as required
15by this Act.
16    (e) Funding.
17        (1) On and after October 1, 2025, any manufacturer of
18    products containing methamphetamine precursors sold in or
19    brought into this State must, on a monthly basis, pay fees
20    to the Central Repository.
21        (2) The Central Repository shall be responsible for
22    setting the fee levels required under paragraph (1).
23        (3) At the request of the Illinois State Police,
24    manufacturers required to pay fees under paragraph (1)
25    shall be required to provide written documentation
26    demonstrating that they have paid such fees.

 

 

HB3087 Engrossed- 6 -LRB104 09442 RLC 19502 b

1        (4) The sale of methamphetamine precursors in or
2    brought into this State by a manufacturer who has failed
3    to pay fees required under paragraph (1) shall be
4    considered a violation of this Section and shall subject
5    the manufacturer to the penalties outlined in subsection
6    (c) of Section 30.
7        (5) Nothing in this subsection (e) applies to a
8    manufacturer of products containing methamphetamine
9    precursors sold in or brought into this State that are
10    available only pursuant to a valid prescription.
11        (6) Funding for the tracking program shall be provided
12    by the Illinois State Police drawing upon federal and
13    State grant money and other available sources.
14(Source: P.A. 97-670, eff. 1-19-12.)
 
15    (720 ILCS 649/30)
16    Sec. 30. Violations.
17    (a) Any covered pharmacy or retail distributor that
18violates this Act is guilty of a petty offense and subject to a
19fine of $500 for a first offense; $1,000 for a second offense
20occurring at the same retail location as and within 3 years of
21the offense; and $5,000 for a third or subsequent offense
22occurring at the same retail location as and within 3 years of
23the prior offenses.
24    (b) An employee or agent of a covered pharmacy who
25violates this Act is guilty of a Class A misdemeanor for a

 

 

HB3087 Engrossed- 7 -LRB104 09442 RLC 19502 b

1first offense; a Class 4 felony for a second offense; and a
2Class 1 felony for a third or subsequent offense.
3    (c) Any manufacturer that violates subsection (e) of
4Section 15 of this Act is guilty of a petty offense and subject
5to a fine of $500 for a first offense; $1,000 for a second
6offense occurring within 3 years of the first offense; and
7$5,000 for a third or subsequent offense occurring within 3
8years of the prior offenses.
9(Source: P.A. 97-670, eff. 1-19-12.)
 
10    Section 99. Effective date. This Act takes effect upon
11becoming law.